Effectiveness of omalizumab in patients with severe allergic asthma with and without chronic rhinosinusitis with nasal polyps: a PROXIMA study post hoc analysis

Effectiveness of omalizumab in patients with severe allergic asthma with and without chronic rhinosinusitis with nasal polyps: a PROXIMA study post hoc analysis

Abstract Background A significant proportion of patients with severe asthma may also suffer from nasal polyposis, which is commonly defined as chronic rhinosinusitis with nasal polyps (CRSwNP), the presence of which may adversely affect asthma treatment outcomes. The biologic agent omalizumab is eff...

Full description

Bibliographic Details
Main Authors: Enrico Heffler, Fabiana Saccheri, Marta Bartezaghi, Giorgio Walter Canonica
Format: Article
Language:English
Published: Wiley 2020-06-01
Series:Clinical and Translational Allergy
Subjects:
Biologics
Exacerbations
Nasal Polyps
Observational
Omalizumab
Severe asthma
Online Access:http://link.springer.com/article/10.1186/s13601-020-00330-1

Internet

http://link.springer.com/article/10.1186/s13601-020-00330-1

Similar Items